COMMUNIQUÉS West-GlobeNewswire

-
Rhizen Pharmaceuticals S.A. announces clinical data presentations for Tenalisib (RP6530) in R/R T-cell lymphoma at the upcoming 10th Annual T-Cell Lymphoma Forum in La Jolla, CA, USA
29/01/2018 -
Microbix Featured at Cantech Investment Conference
29/01/2018 -
Protalix BioTherapeutics to Participate in the 14th Annual WORLDSymposium™ 2018
29/01/2018 -
Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the United States
29/01/2018 -
Athersys CEO to Speak at the 2018 Brain Health Summit
29/01/2018 -
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
29/01/2018 -
SuperSonic Imagine to Present Aixplorer® Ultimate at the Arab Health Congress
29/01/2018 -
Correction to company release dated January 26, 2018 - Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - number of shares
29/01/2018 -
Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S
29/01/2018 -
CORRECTION:Sanofi va acquérir Ablynx pour 3,9 milliards d'euros
29/01/2018 -
Proposals of the Shareholders' Nomination Board of Terveystalo Plc to the Annual General Meeting 2018
29/01/2018 -
Reminder Invitation webcast Year-end report 2017
29/01/2018 -
CellaVision AB presents the year-end bulletin for 2017 on February 9 at 11:00 CET
29/01/2018 -
SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION
29/01/2018 -
Sanofi to acquire Ablynx for €3.9 Billion
29/01/2018 -
Sanofi va acquérir Ablynx pour 3,9 milliards d'euros
29/01/2018 -
Santhera Reports Preliminary Key Financial Figures for 2017 and Provides Corporate Update
29/01/2018 -
MediciNova Announces MN-001 (tipelukast) NASH/NAFLD Phase 2 Trial Interim Results Selected for Presentation at the International Liver Congress 2018 in Paris, France
29/01/2018 -
VBI Vaccines Announces Changes to its Board of Directors
26/01/2018
Pages